Inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients while also showing potential against other respiratory infections. With its unique triple-action benefits, ...
Heparin, a widely available drug traditionally used to treat blood clots, lowers risk of death and ventilation in patients with COVID-19. The corresponding study was published in eClinical Medicine.
Respiratory infectious diseases, such as viral pneumonia, pose a serious threat to global public health. These diseases spread rapidly and widely, potentially causing severe complications such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results